Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China Pharmaceutical Investing
Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation Biotech Investing
Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration Biotech Investing
Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics Biotech Investing
Nanotechnology Transforming Delivery Systems for Cannabinoids and Pharmaceuticals Cannabis Investing News
GoverMedia Plus Canada Corp. Announces Commercial Partnership With One of the Largest European Cryptocurrency Exchanges Biotech Investing
Kalytera Announces Second Payments Agreement with The Salzman Group of Israel Cannabis Investing News
Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases Biotech Investing
FDA Approves Merck’s KEYTRUDA (pembrolizumab) for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma Pharmaceutical Investing
